Clinical Trial Update: Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with gemcitabine, docetaxel, melphalan, and carboplatin in ovarian cancer; the study was terminated and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• Melphalan (Melphalan)
• Taxotere (docetaxel)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-05-21